Clinical Biochemical Genetics · Gainesville, FL
NPI
1831205632
Since 2006
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 SW Archer Rd
Gainesville, FL, 32610
Phone (352) 627-9350
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
81 prescriptions
Company payments, 2023
$12.75
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Cheryl L Garganta prescribed most often to Medicare patients was Orfadin (Nitisinone), with 25 prescriptions and refills. In total Cheryl L Garganta wrote 81 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Orfadin Nitisinone | 25 | 25 | Under 11 | $182K |
| Palynziq Pegvaliase-Pqpz | 21 | 21 | Under 11 | $315K |
| Ravicti Glycerol Phenylbutyrate | 17 | 17 | Under 11 | $1.2M |
Brand drugs: 72 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Cheryl L Garganta $12.75 ($12.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Travere Therapeutics, Inc. with $12.75.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 2 | $12.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.